Suresh Alahari

Suresh Alahari is a Senior Professor at Louisiana State University Health Sciences Center, New Orleans. His research focuses on breast cancer cell biology, tumor biology, and molecular cancer, with particular emphasis on oncogenes, tumor suppressors, and cancer pharmacology. His latest work investigates the tumor suppressor function of NISCH in breast cancer, Brigatinib-based degraders as a therapeutic strategy for triple-negative breast cancer, and the oncogenic effects of extracellular matrix remodeling in obesity-associated breast cancer. He has also contributed to studies on Caveolin-1's ambiguous role in breast cancer, CDK4/6 inhibitors, and NUAK kinase signaling mechanisms. His recent publications appear in venues including Cancer Research, Molecular Cancer, Oncogene, and the Journal of Biological Chemistry.